Development of selected reaction monitoring-MS methodology to measure peptide biomarkers in prostate cancer.
Proteomics
; 10(19): 3506-14, 2010 Oct.
Article
in En
| MEDLINE
| ID: mdl-20821805
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Biomarkers, Tumor
/
Prostate-Specific Antigen
/
Tandem Mass Spectrometry
Type of study:
Diagnostic_studies
Limits:
Humans
/
Male
Language:
En
Year:
2010
Type:
Article